I was diagnosed in 1980 and I was a participant in the Phase III trial of Avonex. It was my first DMT and moved from it to Tysabri, Aubagio and, most recently, Lemtrada. It’s always been a consultation between my neuro and me, taking into account risks, benefits and cost. And, it’s always a balancing act. Cathy’s neuro suggested Ocrevus as one of her 3 choices. I have to wonder why Ocrevus and not Lemtrada.